XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Operating Activities:    
Net income $ 1,135,206 $ 975,703
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 115,633 102,343
Amortization 26,874 30,849
Loss (gain) on sale or disposal of property and equipment 375 (48)
Unrealized foreign currency gains (37,606) (25,486)
Deferred income taxes 19,324 (53,966)
Stock compensation expense 125,003 101,039
Realized loss on marketable securities 857 29
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts 68,818 (103,567)
Inventories (324,880) (163,865)
Other current and non-current assets (18,466) (47,413)
Accounts payable (7,531) 124,315
Other current and non-current liabilities 1,944 (6,987)
Deferred revenue (11,603) 5,885
Deferred costs 8,703 (3,987)
Income Taxes (23,077) 13,737
Net cash provided by operating activities 1,079,574 948,581
Investing activities:    
Purchases of property and equipment (146,273) (108,869)
Purchase of marketable securities (724,091) (363,783)
Redemption of marketable securities 531,804 277,334
Net (payments for) cash from acquisitions (175,655) 5,011
Other investing activities, net 387 (458)
Net cash used in investing activities (513,828) (190,765)
Financing activities:    
Dividends (490,919) (428,373)
Proceeds from issuance of treasury shares related to equity awards 29,065 24,530
Purchase of treasury shares related to equity awards (33,476) (16,313)
Purchase of treasury shares under share repurchase plan (130,149) (29,278)
Net cash used in financing activities (625,479) (449,434)
Effect of exchange rate changes on cash and cash equivalents 53,125 7,536
Net (decrease) increase in cash, cash equivalents, and restricted cash (6,608) 315,918
Cash, cash equivalents, and restricted cash at beginning of period 2,080,154 1,694,156
Cash, cash equivalents, and restricted cash at end of period $ 2,073,546 $ 2,010,074